Trial Profile
A Phase 2b trial of Rabexiomod in patients with moderate rheumatoid arthritis (RA)
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 May 2018
At a glance
- Drugs Rabeximod (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 03 May 2018 New trial record